MabThera (rituximab) 500 mg, Roche, Germany, original Order MabThera (rituximab) 500 mg, Roche, Germany, original. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Contact +380996042415.

Interchangeable drugs with the same active substance:

• Mabthera
• Reditux
• Rituxim
• Acellbia

Indications.

• MabThera®is indicated for adults in the following cases:
• non-Hodgkin's lymphoma
• Monotherapy for patients with follicular lymphoma Stage III-IV, resistant to chemotherapy or are in the stage of second or subsequent relapses after chemotherapy.
• Treatment of CD20-positive diffuse large B-cell non-Hodgkin lymphoma in combination with chemotherapy according to the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, prednisolone).
• Earlier treatment untreated follicular lymphoma stage III-IV in combination with chemotherapy.
• Maintenance therapy of follicular lymphomas after receiving a response to induction therapy.
• chronic lymphocytic leukemia
• Treatment of previously untreated and recurrent / refractory chronic lymphocytic leukemia in combination with chemotherapy. There are only limited data regarding the effectiveness and safety of use in patients previously treated with monoclonal antibodies, including MabThera®, or in patients refractory to previous treatment with MabThera®plus chemotherapy.
• rheumatoid arthritis
• Treatment of severe rheumatoid arthritis (active form) in adults in combination with methotrexate when treatment with other disease-modifying antirheumatic drugs (DMARDs) is ineffective or intolerant, including treatment with one or more tumor necrosis factor inhibitors.
• When used in combination with methotrexate Mabthera®reduces the rate of progression of destructive changes in joints according to X-ray data and improves physical function.
• Granulomatosis with polyangiitis and microscopic polyangiitis
• Treatment of severe forms of active granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis in combination with GCS to induce remission in adult patients
•